为凝血异常患者插入中心静脉导管前进行血浆输注。
Plasma transfusions prior to insertion of central lines for patients with abnormal coagulation.
作者信息
Hall David P, Estcourt Lise J, Doree Carolyn, Hopewell Sally, Trivella Marialena, Walsh Timothy S
机构信息
Critical Care and Anaesthetics, NHS Lothian, Edinburgh, UK.
Haematology/Transfusion Medicine, NHS Blood and Transplant, Oxford, UK.
出版信息
Cochrane Database Syst Rev. 2015 Jun 20;2015(6). doi: 10.1002/14651858.CD011756.
Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effect of different prophylactic plasma transfusion regimens prior to central line insertion in patients with abnormal coagulation.
摘要
这是一项综述的方案，没有摘要。目的如下：评估不同预防性血浆输注方案对凝血异常患者中心静脉置管前的影响。
相似文献
1
Plasma transfusions prior to insertion of central lines for patients with abnormal coagulation.
Cochrane Database Syst Rev. 2015 Jun 20;2015(6). doi: 10.1002/14651858.CD011756.
2
Plasma transfusions prior to insertion of central lines for people with abnormal coagulation.
Cochrane Database Syst Rev. 2016 Sep 20;9(9):CD011756. doi: 10.1002/14651858.CD011756.pub2.
3
Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation.
Cochrane Database Syst Rev. 2017 Sep 25;9(9):CD012497. doi: 10.1002/14651858.CD012497.pub2.
4
Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia.
Cochrane Database Syst Rev. 2015 Dec 2;2015(12):CD011771. doi: 10.1002/14651858.CD011771.pub2.
5
Plasma transfusions prior to insertion of central lines for people with abnormal coagulation.
Nurs Stand. 2018 Feb 7;32(24):41-43. doi: 10.7748/ns.2018.e11098.
6
The effect and duration of prophylactic platelet transfusions before insertion of a central venous catheter in patients with bone marrow failure evaluated with point-of-care methods and flow cytometry.
Anesth Analg. 2014 Oct;119(4):882-890. doi: 10.1213/ANE.0000000000000259.
7
Prophylactic platelet transfusions prior to surgery for people with a low platelet count.
Cochrane Database Syst Rev. 2018 Sep 17;9(9):CD012779. doi: 10.1002/14651858.CD012779.pub2.
8
Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia.
Cochrane Database Syst Rev. 2015 Jun 23;2015(6). doi: 10.1002/14651858.CD011771.
9
Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures.
Cochrane Database Syst Rev. 2019 Nov 28;11(11):CD012745. doi: 10.1002/14651858.CD012745.pub2.
10
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD004269. doi: 10.1002/14651858.CD004269.pub3.
引用本文的文献
1
Extracorporeal immune cell therapy of sepsis: ex vivo results.
Intensive Care Med Exp. 2022 Jun 16;10(1):26. doi: 10.1186/s40635-022-00453-8.
2
CIRSE Standards of Practice on Peri-operative Anticoagulation Management During Interventional Radiology Procedures.
Cardiovasc Intervent Radiol. 2021 Apr;44(4):523-536. doi: 10.1007/s00270-020-02763-4. Epub 2021 Jan 20.
3
Plasma transfusions prior to insertion of central lines for people with abnormal coagulation.
Cochrane Database Syst Rev. 2016 Sep 20;9(9):CD011756. doi: 10.1002/14651858.CD011756.pub2.
本文引用的文献
1
Bleeding and coagulopathies in critical care.
N Engl J Med. 2014 Feb 27;370(9):847-59. doi: 10.1056/NEJMra1208626.
2
Central venous catheters.
BMJ. 2013 Nov 11;347:f6570. doi: 10.1136/bmj.f6570.
3
Factors associated with prophylactic plasma transfusion before vascular catheterization in non-bleeding critically ill adults with prolonged prothrombin time: a case-control study.
Br J Anaesth. 2012 Dec;109(6):919-27. doi: 10.1093/bja/aes337. Epub 2012 Sep 30.
4
Plasma components: properties, differences, and uses.
Transfusion. 2012 May;52 Suppl 1:9S-19S. doi: 10.1111/j.1537-2995.2012.03622.x.
5
Transfusion-associated circulatory overload after plasma transfusion.
Transfusion. 2012 Jan;52(1):160-5. doi: 10.1111/j.1537-2995.2011.03247.x. Epub 2011 Jul 18.
6
The conundrum of persistent inappropriate use of frozen plasma.
Crit Care. 2011;15(3):160. doi: 10.1186/cc10215. Epub 2011 May 25.
7
A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.
Crit Care. 2011;15(2):R108. doi: 10.1186/cc10129. Epub 2011 Apr 5.
8
A national clinical scenario-based survey of clinicians' attitudes towards fresh frozen plasma transfusion for critically ill patients.
Transfus Med. 2011 Apr;21(2):124-9. doi: 10.1111/j.1365-3148.2010.01049.x. Epub 2010 Nov 10.
9
The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children.
Transfusion. 2011 Jan;51(1):62-70. doi: 10.1111/j.1537-2995.2010.02798.x. Epub 2010 Aug 27.
10
Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units.
Crit Care Med. 2010 Oct;38(10):1939-46. doi: 10.1097/CCM.0b013e3181eb9d2b.
Zotero 插件